IN2009KN03959A - - Google Patents
Download PDFInfo
- Publication number
- IN2009KN03959A IN2009KN03959A IN3959KON2009A IN2009KN03959A IN 2009KN03959 A IN2009KN03959 A IN 2009KN03959A IN 3959KON2009 A IN3959KON2009 A IN 3959KON2009A IN 2009KN03959 A IN2009KN03959 A IN 2009KN03959A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutically acceptable
- relates
- patient
- administering
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91298007P | 2007-04-20 | 2007-04-20 | |
| PCT/US2008/005084 WO2008130669A1 (en) | 2007-04-20 | 2008-04-21 | Benzimidazoles and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009KN03959A true IN2009KN03959A (https=) | 2015-08-28 |
Family
ID=39875833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3959KON2009 IN2009KN03959A (https=) | 2007-04-20 | 2008-04-21 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8232410B2 (https=) |
| EP (1) | EP2154966B1 (https=) |
| JP (1) | JP5400032B2 (https=) |
| CN (1) | CN101677553A (https=) |
| AU (1) | AU2008242488B2 (https=) |
| BR (1) | BRPI0810244A2 (https=) |
| CA (1) | CA2684594C (https=) |
| DK (1) | DK2154966T3 (https=) |
| EA (1) | EA016726B1 (https=) |
| ES (1) | ES2434693T3 (https=) |
| HR (1) | HRP20131103T1 (https=) |
| IN (1) | IN2009KN03959A (https=) |
| MX (1) | MX2009011281A (https=) |
| PL (1) | PL2154966T3 (https=) |
| PT (1) | PT2154966E (https=) |
| SI (1) | SI2154966T1 (https=) |
| WO (1) | WO2008130669A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8232310B2 (en) | 2006-12-29 | 2012-07-31 | Georgetown University | Targeting of EWS-FLI1 as anti-tumor therapy |
| US8039502B2 (en) | 2007-07-24 | 2011-10-18 | The Ohio State University Research Foundation | Anti-infective agents against intracellular pathogens |
| US20120108823A1 (en) | 2009-04-22 | 2012-05-03 | The Ohio State University Research Foundation | Anti-francisella agents |
| JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| WO2013116823A1 (en) * | 2012-02-02 | 2013-08-08 | The Research Foundation Of State University Of New York | Benzimidazoles and uses thereof |
| WO2013142326A1 (en) * | 2012-03-23 | 2013-09-26 | The Research Foundation Of State University Of New York | 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis |
| CN107011242B (zh) * | 2012-04-12 | 2020-08-07 | 乔治城大学 | 用于治疗尤文肉瘤家族肿瘤的方法和组合物 |
| CN103333170B (zh) * | 2013-06-14 | 2016-08-10 | 清华大学 | 苯并咪唑类化合物及其用途 |
| AU2014340398A1 (en) | 2013-10-24 | 2016-06-09 | Georgetown University | Methods and compositions for treating cancer |
| WO2015077276A1 (en) | 2013-11-22 | 2015-05-28 | The Research Foundation For The State University Of New York | Benzimidazoles and their use in the treatment of tuberculosis |
| US10287617B2 (en) | 2014-03-11 | 2019-05-14 | Colorado State University Research Foundation | Methods for in vitro—in vivo efficacy determination |
| WO2015193506A1 (en) * | 2014-06-20 | 2015-12-23 | Institut Pasteur Korea | Anti-infective compounds |
| CN107108580B (zh) | 2014-10-09 | 2020-06-30 | 英克特诺治疗公司 | 吲哚酮化合物及其用途 |
| EP3795563B1 (en) | 2016-03-31 | 2024-07-17 | Oncternal Therapeutics, Inc. | Indoline analogs and uses thereof |
| CA3029851A1 (en) | 2016-07-29 | 2018-02-01 | Oncternal Therapeutics, Inc. | Uses of indoline compounds such as tk216 for the treatment of cancer |
| CN111303092B (zh) * | 2020-04-07 | 2021-05-25 | 山东昌邑灶户盐化有限公司 | 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用 |
| KR20240035820A (ko) | 2021-07-09 | 2024-03-18 | 플렉시움 인코포레이티드 | Ikzf2를 조절하는 아릴 화합물 및 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61170732A (ja) * | 1985-01-25 | 1986-08-01 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| US7405235B2 (en) * | 2001-05-04 | 2008-07-29 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| EP1805147B1 (en) * | 2004-09-30 | 2014-08-13 | Janssen Pharmaceutica NV | Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| EP2008210A1 (en) | 2006-03-15 | 2008-12-31 | Csir | Modulation of phosphoryl transferase activity of glutamine synthetase |
-
2008
- 2008-04-21 MX MX2009011281A patent/MX2009011281A/es active IP Right Grant
- 2008-04-21 EA EA200901423A patent/EA016726B1/ru not_active IP Right Cessation
- 2008-04-21 WO PCT/US2008/005084 patent/WO2008130669A1/en not_active Ceased
- 2008-04-21 ES ES08799882T patent/ES2434693T3/es active Active
- 2008-04-21 BR BRPI0810244-9A patent/BRPI0810244A2/pt not_active Application Discontinuation
- 2008-04-21 JP JP2010504113A patent/JP5400032B2/ja not_active Expired - Fee Related
- 2008-04-21 IN IN3959KON2009 patent/IN2009KN03959A/en unknown
- 2008-04-21 PL PL08799882T patent/PL2154966T3/pl unknown
- 2008-04-21 SI SI200831097T patent/SI2154966T1/sl unknown
- 2008-04-21 DK DK08799882.9T patent/DK2154966T3/da active
- 2008-04-21 CA CA2684594A patent/CA2684594C/en active Active
- 2008-04-21 US US12/596,347 patent/US8232410B2/en not_active Expired - Fee Related
- 2008-04-21 EP EP08799882.9A patent/EP2154966B1/en not_active Not-in-force
- 2008-04-21 AU AU2008242488A patent/AU2008242488B2/en not_active Ceased
- 2008-04-21 PT PT87998829T patent/PT2154966E/pt unknown
- 2008-04-21 CN CN200880021064A patent/CN101677553A/zh active Pending
- 2008-04-21 HR HRP20131103AT patent/HRP20131103T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100256203A1 (en) | 2010-10-07 |
| PL2154966T3 (pl) | 2014-03-31 |
| JP5400032B2 (ja) | 2014-01-29 |
| CA2684594C (en) | 2015-10-06 |
| CN101677553A (zh) | 2010-03-24 |
| MX2009011281A (es) | 2010-03-08 |
| EP2154966A1 (en) | 2010-02-24 |
| EP2154966B1 (en) | 2013-08-21 |
| EA016726B1 (ru) | 2012-07-30 |
| AU2008242488A1 (en) | 2008-10-30 |
| ES2434693T3 (es) | 2013-12-17 |
| JP2010524947A (ja) | 2010-07-22 |
| AU2008242488B2 (en) | 2014-10-30 |
| BRPI0810244A2 (pt) | 2014-09-30 |
| PT2154966E (pt) | 2013-11-13 |
| EP2154966A4 (en) | 2010-12-15 |
| CA2684594A1 (en) | 2008-10-30 |
| US8232410B2 (en) | 2012-07-31 |
| SI2154966T1 (sl) | 2014-02-28 |
| WO2008130669A1 (en) | 2008-10-30 |
| EA200901423A1 (ru) | 2010-06-30 |
| HRP20131103T1 (hr) | 2013-12-20 |
| DK2154966T3 (da) | 2013-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009KN03959A (https=) | ||
| UA114726C2 (uk) | 1,4-дизаміщені аналоги піридазину та способи лікування пов'язаних з дефіцитом smn станів | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| CY1116989T1 (el) | C-28 αμινες c-3 τροποποιημενων παραγωγων βετουλινικου οξεος ως αναστολεις hiv ωριμανσης | |
| PH12015500719A1 (en) | Gdf-8-inhibitors | |
| TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
| MY145795A (en) | Pyrazoline compounds | |
| NZ600874A (en) | Fluorinated derivatives of deferiprone | |
| CY1119118T1 (el) | Θεραπευτικος παραγων για τις διαταραχες της διαθεσης | |
| WO2011014825A3 (en) | Antiangiogenic small molecules and methods of use | |
| AU2009331669A8 (en) | Dihydropyridone amides as P2X7 modulators | |
| MX341341B (es) | Derivados de benzamida y su uso como inhibidores de proteina de choque termico 90 kda (hsp90). | |
| MX2012013879A (es) | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. | |
| MX2009010374A (es) | Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos. | |
| MX2012008509A (es) | Agente terapeutico o profilactic para enfermedades del tracto biliar. | |
| PH12015500012B1 (en) | Benzodioxole derivative and preparation method and use thereof | |
| BRPI0917245B8 (pt) | compostos derivados de isoquinolinona e sua composição farmacêutica | |
| MX2009005798A (es) | Recuperacion de apoplejia. | |
| PH12014500381A1 (en) | Therapeutic methods | |
| CY1119483T1 (el) | Θεραπευτικος παραγων για τις αγχωδεις διαταραχες | |
| PH12012501476A1 (en) | Aminoquinoline derivatives | |
| MX2012012410A (es) | Agente terapeutico y agente preventivo para enfermedad de alzheimer. |